Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 99942Apophison Sep 24, 2023 10:27pm
164 Views
Post# 35651551

RE:RE:RE:RE:RE:Bored. Waiting. Here is some playing with data to look at.

RE:RE:RE:RE:RE:Bored. Waiting. Here is some playing with data to look at. I see we once again are using the "cure word" although its far too early for that title,  perhaps continued CR durability can be more accurate until a greater time frame can back it up.  Yes 40% is what we can be expected as a ok threshold for now however I believe most of us can hope for a strong possibility of reaching 55% or better for the final outcome.  Honestly I've had a difficult time accepting anything below 85% only because in theory Ruvidar should work extremely well in the destruction of Cancer. At least the company is learning much about their fight for other indications through the first of many battles with that horrible disease.  
<< Previous
Bullboard Posts
Next >>